United States· US:63539-236_0043f6db-decd-4d53-a301-35f2f7a63664

CIBINQO

A abrocitinib product containing abrocitinib, registered in United States by U.S. Pharmaceuticals. The same ATC class is registered in 15 of our 19 countries.

ATC D11AH08Orange BookUS label

Checked against FDA National Drug Code directory (United States) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about abrocitinibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Abrocitinib is registered in 15 of 19 countries.

Countries holding a registration under ATC D11AH08 (abrocitinib), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search abrocitinib products by name

Abrocitinib · ATC D11AH08

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abrocitinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.26 in France to $295.64 in United States — a ×1143 gap.

United States: $295.64 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Abrocitinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

US United States$295.64 (acquisition cost)
CH Switzerland$122.11
FR France$0.26

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: abrocitinib
Manufacturer: U.S. Pharmaceuticals
Country: United States (US)
ATC code: D11AH08
ATC class: Abrocitinib
Defined daily dose: 0.15 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 12, 2026

Packs & prices · 1

ndc11
6353923614
14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14)

Regulatory notes

UNII (FDA substance ID)

73SM5SF3OR

ABROCITINIB

RxCUI 2591476

Orange Book

N213871

DailyMed SPL labels

1 version tracked

Same medicine, other countries

Abrocitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abrocitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Cibinqo
Liechtenstein · Cibinqo
Norway · Cibinqo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/df47d110-0a23-4dad-b165-70a8bdd4f1f6
GET /v1/drugs/df47d110-0a23-4dad-b165-70a8bdd4f1f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "73SM5SF3OR",
    "rxcui": "2591476",
    "inchikey": "IUEWXNHSKRWHDY-PHIMTYICSA-N",
    "display_name": "ABROCITINIB",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "16c12a56-4550-414b-ac9d-b785b41fea6b": {
      "match": "brand_token",
      "title": "CIBINQO (ABROCITINIB) TABLET, FILM COATED [U.S. PHARMACEUTICALS]",
      "spl_version": "4",
      "published_date": "2025-03-24"
    }
  },
  "productid": "63539-236_0043f6db-decd-4d53-a301-35f2f7a63664",
  "productndc": "63539-236",
  "dosage_form": "TABLET, FILM COATED",
  "orange_book": {
    "appl_no": "213871",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "50MG",
        "product_no": "001",
        "approval_date": "Jan 14, 2022"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "100MG",
        "product_no": "002",
        "approval_date": "Jan 14, 2022"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "200MG",
        "product_no": "003",
        "approval_date": "Jan 14, 2022"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ABROCITINIB",
  "proprietary_name": "CIBINQO",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA213871",
  "marketing_category": "NDA",
  "nonproprietary_name": "abrocitinib",
  "start_marketing_date": "20220224",
  "active_numerator_strength": "50"
}

API reference MCP server Plans

See everything about abrocitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console